Vor Biopharma (VOR) Stock Statistics & Valuation Metrics

Vor Biopharma has a market cap or net worth of $179.23M. The enterprise value is $158.13M.

Vor Biopharma has 21,910,630 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vor Biopharma’s return on equity (ROE) is -1.21 and return on invested capital (ROIC) is -94.31%.

The current PE Ratio of Vor Biopharma is ―. Vor Biopharma’s PEG ratio is 0.23.

In the last 12 months, Vor Biopharma had revenue of 0.00 and earned -116.91M in profits. Earnings per share was -34.00.

In the last 12 months, operating cash flow was -143.97M and capital expenditures -699.00K, giving a free cash flow of -144.67M billion.

Vor Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Vor Biopharma upcoming earnings date is Mar 19, 2026, Before Open (Confirmed).

Vor Biopharma as a current ratio of 5.19, with Debt / Equity ratio of -0.14%

In the past 12 months, Vor Biopharma has paid 0.00 in taxes.

Vor Biopharma EV to EBITDA ratio is -0.22, with an EV/FCF ratio of -0.26.

Vor Biopharma has $170.46M in cash and marketable securities with $3.06M in debt, giving a net cash position of $167.40M billion.

Gross margin is 50.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Vor Biopharma is $40.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy